Cargando…
Periostin-binding DNA aptamer treatment attenuates renal fibrosis under diabetic conditions
Diabetic nephropathy, the major cause of chronic kidney disease, is associated with progressive renal fibrosis. Recently, accumulation of periostin, an extracellular matrix protein, was shown to augment renal fibrosis. Aptamers have higher binding affinities without developing the common side effect...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5561139/ https://www.ncbi.nlm.nih.gov/pubmed/28819200 http://dx.doi.org/10.1038/s41598-017-09238-6 |
_version_ | 1783257784181063680 |
---|---|
author | Um, Jae Eun Park, Jung Tak Nam, Bo Young Lee, Jung Pyo Jung, Jong Ha Kim, Youndong Kim, Seonghun Park, Jimin Wu, Meiyan Han, Seung Hyeok Yoo, Tae-Hyun Kang, Shin-Wook |
author_facet | Um, Jae Eun Park, Jung Tak Nam, Bo Young Lee, Jung Pyo Jung, Jong Ha Kim, Youndong Kim, Seonghun Park, Jimin Wu, Meiyan Han, Seung Hyeok Yoo, Tae-Hyun Kang, Shin-Wook |
author_sort | Um, Jae Eun |
collection | PubMed |
description | Diabetic nephropathy, the major cause of chronic kidney disease, is associated with progressive renal fibrosis. Recently, accumulation of periostin, an extracellular matrix protein, was shown to augment renal fibrosis. Aptamers have higher binding affinities without developing the common side effects of antibodies. Thus, we evaluated the effect of periostin inhibition by an aptamer-based inhibitor on renal fibrosis under diabetic conditions. In vitro, transforming growth factor-β1 (TGF-β1) treatment significantly upregulated periostin, fibronectin, and type I collagen mRNA and protein expressions in inner medullary collecting duct (IMCD) cells. These increases were attenuated significantly in periostin-binding DNA aptamer (PA)-treated IMCD cells exposed to TGF-β1. In vivo, PA treatment attenuated the increased blood urea nitrogen levels in the diabetic mice significantly. Fibronectin and type I collagen mRNA and protein expressions increased significantly in the kidneys of diabetic mice: PA administration abrogated these increases significantly. Immunohistochemistry and Sirius Red staining also revealed that fibronectin expression was significantly higher and tubulointersititial fibrosis was significantly worse in diabetic mice kidneys compared with control mice. These changes were ameliorated by PA treatment. These findings suggested that inhibition of periostin using a DNA aptamer could be a potential therapeutic strategy against renal fibrosis in diabetic nephropathy. |
format | Online Article Text |
id | pubmed-5561139 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-55611392017-08-18 Periostin-binding DNA aptamer treatment attenuates renal fibrosis under diabetic conditions Um, Jae Eun Park, Jung Tak Nam, Bo Young Lee, Jung Pyo Jung, Jong Ha Kim, Youndong Kim, Seonghun Park, Jimin Wu, Meiyan Han, Seung Hyeok Yoo, Tae-Hyun Kang, Shin-Wook Sci Rep Article Diabetic nephropathy, the major cause of chronic kidney disease, is associated with progressive renal fibrosis. Recently, accumulation of periostin, an extracellular matrix protein, was shown to augment renal fibrosis. Aptamers have higher binding affinities without developing the common side effects of antibodies. Thus, we evaluated the effect of periostin inhibition by an aptamer-based inhibitor on renal fibrosis under diabetic conditions. In vitro, transforming growth factor-β1 (TGF-β1) treatment significantly upregulated periostin, fibronectin, and type I collagen mRNA and protein expressions in inner medullary collecting duct (IMCD) cells. These increases were attenuated significantly in periostin-binding DNA aptamer (PA)-treated IMCD cells exposed to TGF-β1. In vivo, PA treatment attenuated the increased blood urea nitrogen levels in the diabetic mice significantly. Fibronectin and type I collagen mRNA and protein expressions increased significantly in the kidneys of diabetic mice: PA administration abrogated these increases significantly. Immunohistochemistry and Sirius Red staining also revealed that fibronectin expression was significantly higher and tubulointersititial fibrosis was significantly worse in diabetic mice kidneys compared with control mice. These changes were ameliorated by PA treatment. These findings suggested that inhibition of periostin using a DNA aptamer could be a potential therapeutic strategy against renal fibrosis in diabetic nephropathy. Nature Publishing Group UK 2017-08-17 /pmc/articles/PMC5561139/ /pubmed/28819200 http://dx.doi.org/10.1038/s41598-017-09238-6 Text en © The Author(s) 2017 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Um, Jae Eun Park, Jung Tak Nam, Bo Young Lee, Jung Pyo Jung, Jong Ha Kim, Youndong Kim, Seonghun Park, Jimin Wu, Meiyan Han, Seung Hyeok Yoo, Tae-Hyun Kang, Shin-Wook Periostin-binding DNA aptamer treatment attenuates renal fibrosis under diabetic conditions |
title | Periostin-binding DNA aptamer treatment attenuates renal fibrosis under diabetic conditions |
title_full | Periostin-binding DNA aptamer treatment attenuates renal fibrosis under diabetic conditions |
title_fullStr | Periostin-binding DNA aptamer treatment attenuates renal fibrosis under diabetic conditions |
title_full_unstemmed | Periostin-binding DNA aptamer treatment attenuates renal fibrosis under diabetic conditions |
title_short | Periostin-binding DNA aptamer treatment attenuates renal fibrosis under diabetic conditions |
title_sort | periostin-binding dna aptamer treatment attenuates renal fibrosis under diabetic conditions |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5561139/ https://www.ncbi.nlm.nih.gov/pubmed/28819200 http://dx.doi.org/10.1038/s41598-017-09238-6 |
work_keys_str_mv | AT umjaeeun periostinbindingdnaaptamertreatmentattenuatesrenalfibrosisunderdiabeticconditions AT parkjungtak periostinbindingdnaaptamertreatmentattenuatesrenalfibrosisunderdiabeticconditions AT namboyoung periostinbindingdnaaptamertreatmentattenuatesrenalfibrosisunderdiabeticconditions AT leejungpyo periostinbindingdnaaptamertreatmentattenuatesrenalfibrosisunderdiabeticconditions AT jungjongha periostinbindingdnaaptamertreatmentattenuatesrenalfibrosisunderdiabeticconditions AT kimyoundong periostinbindingdnaaptamertreatmentattenuatesrenalfibrosisunderdiabeticconditions AT kimseonghun periostinbindingdnaaptamertreatmentattenuatesrenalfibrosisunderdiabeticconditions AT parkjimin periostinbindingdnaaptamertreatmentattenuatesrenalfibrosisunderdiabeticconditions AT wumeiyan periostinbindingdnaaptamertreatmentattenuatesrenalfibrosisunderdiabeticconditions AT hanseunghyeok periostinbindingdnaaptamertreatmentattenuatesrenalfibrosisunderdiabeticconditions AT yootaehyun periostinbindingdnaaptamertreatmentattenuatesrenalfibrosisunderdiabeticconditions AT kangshinwook periostinbindingdnaaptamertreatmentattenuatesrenalfibrosisunderdiabeticconditions |